{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:55:59Z","timestamp":1776408959773,"version":"3.51.2"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"D1","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The US Food and Drug Administration (FDA) and the National Center for Advancing Translational Sciences (NCATS) have collaborated to publish rigorous scientific descriptions of substances relevant to regulated products. The FDA has adopted the global ISO 11238 data standard for the identification of substances in medicinal products and has populated a database to organize the agency's regulatory submissions and marketed products data. NCATS has worked with FDA to develop the Global Substance Registration System (GSRS) and produce a non-proprietary version of the database for public benefit. In 2019, more than half of all new drugs in clinical development were proteins, nucleic acid therapeutics, polymer products, structurally diverse natural products or cellular therapies. While multiple databases of small molecule chemical structures are available, this resource is unique in its application of regulatory standards for the identification of medicinal substances and its robust support for other substances in addition to small molecules. This public, manually curated dataset provides unique ingredient identifiers (UNIIs) and detailed descriptions for over 100 000 substances that are particularly relevant to medicine and translational research. The dataset can be accessed and queried at https:\/\/gsrs.ncats.nih.gov\/app\/substances.<\/jats:p>","DOI":"10.1093\/nar\/gkaa962","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T19:22:39Z","timestamp":1602184959000},"page":"D1179-D1185","source":"Crossref","is-referenced-by-count":24,"title":["Global Substance Registration System: consistent scientific descriptions for substances related to health"],"prefix":"10.1093","volume":"49","author":[{"given":"Tyler","family":"Peryea","sequence":"first","affiliation":[{"name":"Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD 20993, USA"},{"name":"Informatics, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4500-880X","authenticated-orcid":false,"given":"Noel","family":"Southall","sequence":"additional","affiliation":[{"name":"Informatics, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"}]},{"given":"Mitch","family":"Miller","sequence":"additional","affiliation":[{"name":"Informatics, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"}]},{"given":"Daniel","family":"Katzel","sequence":"additional","affiliation":[{"name":"Informatics, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"}]},{"given":"Niko","family":"Anderson","sequence":"additional","affiliation":[{"name":"Informatics, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"}]},{"given":"Jorge","family":"Neyra","sequence":"additional","affiliation":[{"name":"Informatics, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"}]},{"given":"Sarah","family":"Stemann","sequence":"additional","affiliation":[{"name":"Informatics, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2591-9948","authenticated-orcid":false,"given":"\u00d0\u1eafc-Trung","family":"Nguy\u1ec5n","sequence":"additional","affiliation":[{"name":"Informatics, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"}]},{"given":"Dammika","family":"Amugoda","sequence":"additional","affiliation":[{"name":"Informatics, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA"}]},{"given":"Archana","family":"Newatia","sequence":"additional","affiliation":[{"name":"Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD 20993, USA"}]},{"given":"Ramez","family":"Ghazzaoui","sequence":"additional","affiliation":[{"name":"Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD 20993, USA"}]},{"given":"Elaine","family":"Johanson","sequence":"additional","affiliation":[{"name":"Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD 20993, USA"}]},{"given":"Herman","family":"Diederik","sequence":"additional","affiliation":[{"name":"College ter Beoordeling van Geneesmiddelen, 3531 AH Utrecht, Netherlands"}]},{"given":"Larry","family":"Callahan","sequence":"additional","affiliation":[{"name":"Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD 20993, USA"}]},{"given":"Frank","family":"Switzer","sequence":"additional","affiliation":[{"name":"Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD 20993, USA"}]}],"member":"286","published-online":{"date-parts":[[2020,11,2]]},"reference":[{"key":"2021010313125783300_B1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fmed.2017.00114","article-title":"Data management in a regulatory context","volume":"4","author":"Gronning","year":"2017","journal-title":"Front. Med. (Lausanne)"},{"key":"2021010313125783300_B2","volume-title":"ISO 11238: 2018. Health informatics \u2014 Identification of medicinal products \u2014 Data elements and structures for the unique identification and exchange of regulated information on substances","author":"International Standards Organization","year":"2020"},{"key":"2021010313125783300_B3","volume-title":"Substance Identification","author":"United States Food and Drug Administration","year":"2020"},{"key":"2021010313125783300_B4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40248-018-0125-8","article-title":"Onsite production of medical air: is purity a problem","volume":"13","author":"Edwards","year":"2018","journal-title":"Multidiscip. Respir. Med."},{"key":"2021010313125783300_B5","volume-title":"ISO\/TS 19844: 2018. Implementation guidelines for ISO 11238 for data elements and structures for the unique identification and exchange of regulated information on substances","author":"International Standards Organization","year":"2020"},{"key":"2021010313125783300_B6","doi-asserted-by":"crossref","first-page":"100009","DOI":"10.1016\/j.jvacx.2019.100009","article-title":"rVSVDeltaG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk\/benefit assessment","volume":"1","author":"Monath","year":"2019","journal-title":"Vaccine X"},{"key":"2021010313125783300_B7","author":"US Food and Drug Administration"},{"key":"2021010313125783300_B8","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1021\/acs.orglett.8b01218","article-title":"Adventures in Atropisomerism: Total Synthesis of a Complex Active Pharmaceutical Ingredient with Two Chirality Axes","volume":"20","author":"Beutner","year":"2018","journal-title":"Org Lett."},{"key":"2021010313125783300_B9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/mec.13491","article-title":"Genomic signature of successful colonization of Eurasia by the allopolyploid shepherd's purse (Capsella bursa-pastoris)","volume":"25","author":"Cornille","year":"2016","journal-title":"Mol. Ecol."},{"key":"2021010313125783300_B10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1089\/acm.2017.0267","article-title":"Effect of hydroalcoholic extracts of capsella bursa-pastoris on heavy menstrual bleeding: a randomized clinical trial","volume":"24","author":"Naafe","year":"2018","journal-title":"J. Altern. Complement. Med."},{"key":"2021010313125783300_B11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13321-015-0068-4","article-title":"InChI, the IUPAC international chemical identifier","volume":"7","author":"Heller","year":"2015","journal-title":"J Cheminform"},{"key":"2021010313125783300_B12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1021\/ci60006a016","article-title":"The chemical abstracts service chemical registry system. I. General Design","volume":"16","author":"Dittmar","year":"1976","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"2021010313125783300_B13","first-page":"239","article-title":"The Food and Drug Administration drug registration and listing system","volume":"9","author":"Slavin","year":"1975","journal-title":"Drug Inf. J."},{"key":"2021010313125783300_B14","first-page":"2696","article-title":"An overview of the FDA publication approved drug products with therapeutic equivalence evaluations","volume":"47","author":"Knoben","year":"1990","journal-title":"Am. J. Hosp. Pharm."},{"key":"2021010313125783300_B15","first-page":"166","article-title":"Excipients and their use in injectable products","volume":"51","author":"Nema","year":"1997","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"2021010313125783300_B16","volume-title":"Substance Registration System Standard Operating Procedure","author":"United States Food and Drug Administration","year":"2007"},{"key":"2021010313125783300_B17","first-page":"1108","article-title":"HL7 Structured Product Labeling - electronic prescribing information for provider order entry decision support","volume":"2005","author":"Schadow","year":"2005","journal-title":"AMIA Annu. Symp. Proc."},{"key":"2021010313125783300_B18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41557-018-0043-6","article-title":"A new fundamental type of conformational isomerism","volume":"10","author":"Canfield","year":"2018","journal-title":"Nat Chem"},{"key":"2021010313125783300_B19","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1021\/jm200584g","article-title":"Assessing atropisomer axial chirality in drug discovery and development","volume":"54","author":"Laplante","year":"2011","journal-title":"J. Med. Chem."},{"key":"2021010313125783300_B20","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1021\/acs.jmedchem.8b00797","article-title":"Atropisomerism by Design: Discovery of a selective and stable phosphoinositide 3-Kinase (PI3K) beta inhibitor","volume":"61","author":"Chandrasekhar","year":"2018","journal-title":"J. Med. Chem."},{"key":"2021010313125783300_B21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2174\/0929867324666170529125229","article-title":"Cyclometalated complexes of platinum and gold with biological properties: state-of-the-art and future perspectives","volume":"25","author":"Jurgens","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"2021010313125783300_B22","doi-asserted-by":"crossref","first-page":"10755","DOI":"10.3390\/molecules190810755","article-title":"Metal complexes containing natural and and artificial radioactive elements and their applications","volume":"19","author":"Kharissova","year":"2014","journal-title":"Molecules"},{"key":"2021010313125783300_B23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/JVI.02265-13","article-title":"Characterization of the envelope glycoprotein of a novel filovirus, lloviu virus","volume":"88","author":"Maruyama","year":"2014","journal-title":"J. Virol."},{"key":"2021010313125783300_B24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/fvl.09.56","article-title":"Ebolavirus glycoprotein structure and mechanism of entry","volume":"4","author":"Lee","year":"2009","journal-title":"Future Virol."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/49\/D1\/D1179\/35364874\/gkaa962.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/49\/D1\/D1179\/35364874\/gkaa962.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T18:17:17Z","timestamp":1609697837000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/49\/D1\/D1179\/5952203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":24,"journal-issue":{"issue":"D1","published-online":{"date-parts":[[2020,11,2]]},"published-print":{"date-parts":[[2021,1,8]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkaa962","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,8]]},"published":{"date-parts":[[2020,11,2]]}}}